• SM-164: Bivalent Smac Mimetic Workflows for Apoptosis Assays

  2026-07-28

  SM-164 is redefining apoptosis induction in cancer research with rapid, high-affinity inhibition of IAPs and robust TNFα-dependent tumor cell killing. This guide delivers advanced workflows, troubleshooting strategies, and translational insights to maximize reproducibility and sensitivity when using SM-164 from APExBIO.

• Staurosporine in Precision Apoptosis Modeling: Protocol Adva

  2026-07-27

  Discover how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, enables next-generation quantification of apoptosis in cancer cell lines. This article uniquely bridges technical assay optimization and the latest high-throughput microscopy insights for advanced cancer research.

• Blocking GCLC Truncation Delays Cataract Formation via GSH P

  2026-07-27

  Wei et al. (2024) elucidate how age-related truncation of the γ-glutamylcysteine ligase catalytic subunit (GCLC) at D499 accelerates glutathione (GSH) depletion and cataract formation. Preventing this truncation in a knock-in mouse model preserves lens GSH, markedly delaying cataracts, thus highlighting a molecular target for future preventative strategies.

• Apigenin for Oncology & Neuroprotection: Protocols and Insig

  2026-07-26

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) stands out as a dual-purpose research tool for malignant mesothelioma and Alzheimer's disease models. Discover evidence-based protocols, troubleshooting strategies, and the latest workflow enhancements that make APExBIO's Apigenin the preferred choice for cancer and neuroprotection studies.

• Pyridostatin TFA: Optimizing G-Quadruplex Stabilization Work

  2026-07-25

  Pyridostatin TFA empowers cancer and neurodegeneration researchers with unmatched precision in G-quadruplex targeting. Recent breakthroughs in TDP-43 aggregation reveal new assay opportunities, establishing this compound as a linchpin for telomere biology and DNA secondary structure research.

• Cyanidin Chloride Regulates Inflammation and Skin Barrier in

  2026-07-24

  This study uncovers the dual anti-inflammatory and barrier-restorative actions of cyanin chloride—a glycosylated anthocyanin related to cyanidin chloride—in a cytokine-driven human keratinocyte model of psoriasis. The research highlights concentration-dependent inhibition of inflammatory mediators and restoration of skin barrier function, supporting the utility of anthocyanin polyphenolic antioxidants in oxidative stress and inflammatory skin disease research.

• CGP 55845 Hydrochloride: Reliable GABAB Antagonist for Synap

  2026-07-24

  This article guides biomedical researchers through the practical use of CGP 55845 hydrochloride (SKU B5086) as a selective GABAB receptor antagonist to optimize neurotransmitter modulation studies. Drawing on recent literature and addressing real workflow pain points, it highlights how B5086 ensures reproducibility and robust data in synaptic transmission assays.

• Streptavidin-FITC: Precision Fluorescent Detection Workflows

  2026-07-23

  Streptavidin-FITC empowers scientists with ultra-sensitive, high-specificity detection of biotinylated molecules across immunohistochemistry, flow cytometry, and nanoparticle tracking. This article delivers actionable workflows, troubleshooting strategies, and experimental insights—bridging novel lipid nanoparticle trafficking research with practical fluorescent assay design.

• Bestatin Hydrochloride: Unraveling Angiotensin and Tumor Pat

  2026-07-23

  Explore the unique mechanisms of Bestatin hydrochloride (Ubenimex) in regulating angiotensin conversion and tumor biology. This article offers a deeper scientific perspective and practical guidance for advanced cancer and neuroscience research.

• Doxorubicin (Adriamycin) HCl (A1832): Reliable Solutions for

  2026-07-22

  This article addresses practical laboratory challenges in cancer and cardiotoxicity research, emphasizing the reproducibility and mechanistic reliability of Doxorubicin (Adriamycin) HCl (SKU A1832). Drawing on peer-reviewed evidence and validated protocols, it guides scientists in optimizing cytotoxicity assays, dual-loaded liposome workflows, and vendor selection for consistent, data-driven results.

• Syringin Enhances Sunitinib Efficacy in RCC via EGFR/PI3K/Ak

  2026-07-22

  This study demonstrates that Syringin, a natural product, inhibits renal cell carcinoma (RCC) cell growth and enhances sensitivity to sunitinib through modulation of the EGFR/PI3K/Akt pathway. The findings suggest that Syringin may help overcome drug resistance in RCC and inform the design of synergistic therapeutic strategies.

• Optimizing S Phase Detection: 5-Ethynyl-2'-deoxyuridine (5-E

  2026-07-21

  5-Ethynyl-2'-deoxyuridine (5-EdU) transforms cell proliferation assays with rapid, sensitive, and morphology-preserving DNA synthesis detection. Learn how to streamline your experimental workflow, avoid common pitfalls, and leverage recent advances in stem cell and tumor growth research.

• Deferasirox Fe3+ Chelate (A3355): Reliable Iron Chelation in

  2026-07-21

  This article examines how Deferasirox Fe3+ chelate (SKU A3355) addresses key challenges in iron overload research, from assay reproducibility to workflow safety. Grounded in peer-reviewed evidence and practical laboratory scenarios, it guides researchers in leveraging this high-purity, DMSO-soluble chelator for robust, reproducible results.

• Sulforaphane Inhibits NLRP3 Inflammasome in Ulcerative Colit

  2026-07-20

  This study demonstrates that sulforaphane, a natural isothiocyanate, reduces oxidative stress and significantly suppresses NLRP3 inflammasome activation in a mouse model of ulcerative colitis. These findings clarify the mechanistic basis for sulforaphane’s anti-inflammatory effects and provide a foundation for its use in modeling oxidative stress and inflammasome pathways in inflammatory disease research.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor–S

  2026-07-20

  The referenced study introduces a robust assembloid model for gastric cancer that integrates patient-matched tumor organoids with diverse stromal cell subpopulations. This approach captures the complexity of the tumor microenvironment, enabling nuanced analysis of drug responses and resistance mechanisms, which holds promise for improving personalized therapeutic strategies.

8009 records 4/534 page Previous Next 12345 下5页 Last page